Health
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2 – News-Medical.Net
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to…
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Tetanus toxoid (TT) is a chemically inactivated version of the tetanus toxin produced by the bacteria Clostridium tetani. This chemically inactivated antigen can be used as a protein carrier in vaccines to induce potent…
-
Business24 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News24 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage
-
Business21 hours agoDoes Macquarie rate Rio Tinto shares a buy, hold or sell after its big news?
-
General24 hours agoBusiness boost as more nuisance tariffs get the chop